We would like to express our gratitude for taking part in the New Directions in IO Conference 2021! We hope you enjoyed the experience - we look forward to seeing you next year! #CoLCentreIO2021#immunotherapy
Hear how Kurt Schalper of Yale is using deep spatial analysis of the tumor immune to understand sensitivity and resistance to immunostimulatory anti-cancer treatments
Cell #barcoding is an important application that may be achieved by integrating #antibodies labeled with cadmium (Cd) into previously defined panels. Cell barcoding enables sample #multiplexing for #singlecell analysis in #masscytometry, leading to:
https://t.co/Z2iIo5pB6m
A key goal of #EDx21 is to spark new collaborations in early detection. @CanaryCenter's Alice Fan explains why this conference offers a unique opportunity for networking.
Join over 300 researchers from across the globe who have already signed up: https://t.co/JQf6IqjP5N
The new e-commerce lab and instrument supply storefront is up and running! Need help transferring your account to the new e-commerce site?
If you have questions or need help transferring your existing Online Order Enablement account, we can support you: https://t.co/2sWuvsfWuJ
Earlier this week the JCVI advised that people with severely weakened immune systems (including some people living with cancer) should be given a third COVID-19 vaccine dose. Read more on our rolling COVID-19 vaccine article 👇 https://t.co/iuLUpUf7v6
Congratulations to Febe Van Maldegem on her recent Amsterdam UMC Fellowship award!
She currently works as a senior postdoc researcher @TheCrick and brings extensive experience using #ImagingMassCytometry to monitor the immune responses to #cancer.
https://t.co/pOgdanIFwf
“I love running. As part of my recovery, I’ve signed up to Cancer Research UK’s Run 60 challenge, which takes place throughout September. I want to do my bit to help raise funds for life-saving research.” Join Jess and sign up to run 60 miles in September: https://t.co/mvCz3GNydq
Thanks for the support @fluidigm! Fluidigm is committed to empowering the cancer immunotherapy community with research tools to interrogate immune cell function and the tumor microenvironment with unprecedented resolution.
Attending New Directions in #ImmunoOncology: Therapies and Stratification?
Join us on Monday 6 September, 17:10 BST, for 'An XT perspective from the Crick’, to learn about the next evolution in affordable and automated high-dimensional #cytometry. #CyTOF
https://t.co/GXhNa2jQx6
Attending New Directions in #ImmunoOncology: Therapies and Stratification?
Join us on Monday 6 September, 17:10 BST, for 'An XT perspective from the Crick’, to learn about the next evolution in affordable and automated high-dimensional #cytometry. #CyTOF
https://t.co/GXhNa2jQx6